NASDAQ, ALXA - Alexza Pharmaceuticals
We are an emerging specialty pharmaceutical company focused on the development
and commercialization of novel, proprietary products for the treatment of acute
and intermittent conditions. We currently have six product candidates in
clinical development. Our technology, the Staccato system, vaporizes
excipient-free drugs to form condensation aerosols that, when inhaled, allows
for rapid systemic drug delivery. Because of the particle size of the aerosol,
the drug is quickly absorbed through the deep lung into the bloodstream,
providing speed of therapeutic onset that is comparable to intravenous, or IV,
administration but with greater ease, patient comfort and convenience.
We have identified approximately 200 drug compounds that have demonstrated
initial vaporization feasibility for delivery with our technology. ...
Read SEC Filing on NASDAQ.com »